The epigenetics of aging and neurodegeneration

被引:263
作者
Lardenoije, Roy [1 ]
Iatrou, Artemis [1 ]
Kenis, Gunter [1 ]
Kompotis, Konstantinos [2 ]
Steinbusch, Harry W. M. [1 ]
Mastroeni, Diego [1 ,3 ]
Coleman, Paul [3 ]
Lemere, Cynthia A. [4 ]
Hof, Patrick R. [5 ,6 ]
van den Hove, Daniel L. A. [1 ,7 ]
Rutten, Bart P. F. [1 ]
机构
[1] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci MHeNS, NL-6200 MD Maastricht, Netherlands
[2] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland
[3] Banner Sun Hlth Res Inst, LJ Roberts Alzheimers Dis Ctr, Sun City, AZ 85351 USA
[4] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA
[5] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA
[7] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, D-97080 Wurzburg, Germany
基金
美国国家卫生研究院;
关键词
Epigenetics; Aging; Neurodegeneration; Alzheimer's disease; Parkinson's disease; Huntington's disease; HISTONE DEACETYLASE INHIBITORS; AMYLOID-PRECURSOR-PROTEIN; LONG-TERM-MEMORY; NF-KAPPA-B; ALPHA-SYNUCLEIN EXPRESSION; ACTIVE DNA DEMETHYLATION; GENOME-WIDE ASSOCIATION; WILD-TYPE HUNTINGTIN; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MOUSE MODEL; PARKINSONS-DISEASE PATIENTS;
D O I
10.1016/j.pneurobio.2015.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and noncoding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:21 / 64
页数:44
相关论文
共 752 条
[1]   Prevalence and clinical correlates of psychotic symptoms in Parkinson disease - A community-based study [J].
Aarsland, D ;
Larsen, JP ;
Cummings, JL ;
Laake, K .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :595-601
[2]   β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death [J].
Abeti, Rosella ;
Abramov, Andrey Y. ;
Duchen, Michael R. .
BRAIN, 2011, 134 :1658-1672
[3]   Epigenetics: A novel therapeutic approach for the treatment of Alzheimer's disease [J].
Adwan, Lina ;
Zawia, Nasser H. .
PHARMACOLOGY & THERAPEUTICS, 2013, 139 (01) :41-50
[4]   The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence [J].
Agger, Karl ;
Cloos, Paul A. C. ;
Rudkjaer, Lise ;
Williams, Kristine ;
Andersen, Gitte ;
Christensen, Jesper ;
Helin, Kristian .
GENES & DEVELOPMENT, 2009, 23 (10) :1171-1176
[5]   Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia [J].
Agirre, X ;
Román-Gómez, J ;
Vázquez, I ;
Jiménez-Velasco, A ;
Garate, L ;
Montiel-Duarte, C ;
Artieda, P ;
Cordeu, L ;
Lahortiga, I ;
Calasanz, MJ ;
Heiniger, A ;
Torres, A ;
Minna, JD ;
Prósper, F .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (08) :1945-1953
[6]   Loss of HDAC5 Impairs Memory Function: Implications for Alzheimer's Disease [J].
Agis-Balboa, Roberto Carlos ;
Pavelka, Zsuzsa ;
Kerimoglu, Cemil ;
Fischer, Andre .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 33 (01) :35-44
[7]   APOBEC3 proteins and reverse transcription [J].
Aguiar, Renato S. ;
Peterlin, B. Matija .
VIRUS RESEARCH, 2008, 134 (1-2) :74-85
[8]   EDITING FOR AN AMPA RECEPTOR SUBUNIT RNA IN PREFRONTAL CORTEX AND STRIATUM IN ALZHEIMERS-DISEASE, HUNTINGTONS-DISEASE AND SCHIZOPHRENIA [J].
AKBARIAN, S ;
SMITH, MA ;
JONES, EG .
BRAIN RESEARCH, 1995, 699 (02) :297-304
[9]   Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus [J].
Akram, Afia ;
Schmeidler, James ;
Katsel, Pavel ;
Hof, Patrick R. ;
Haroutunian, Vahram .
BRAIN RESEARCH, 2010, 1318 :167-177
[10]   Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration [J].
Alarcón, JM ;
Malleret, G ;
Touzani, K ;
Vronskaya, S ;
Ishii, S ;
Kandel, ER ;
Barco, A .
NEURON, 2004, 42 (06) :947-959